Holen Sie sich die Stockscreener-App
1.45
2.03%
-0.03
Finanzdaten der Dare Bioscience Inc-Aktie (DARE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
110.68%
0.00226
|
-0.0212 | 0.0254 | -0.0636 | 0.0417 |
Operating Expenses
|
3.47%
3.6744
|
3.8066 | 4.6065 | 5.3246 | 4.723 |
| Benefits Costs and Expenses |
100.00%
-
|
3.9953 | - | 4.0618 | - |
| Costs And Expenses |
3.47%
3.6744
|
3.8066 | 4.6065 | -14.07 | 4.723 |
| Operating Income/Loss |
4.07%
-3.6721
|
-3.8278 | -4.5811 | -5.3882 | -4.6813 |
| Income/Loss From Continuing Operations Before Tax |
100.06%
0.00226
|
-4.0165 | -4.3783 | -4.1254 | 0.0417 |
| Income/Loss From Continuing Operations After Tax |
11.30%
-3.5628
|
-4.0165 | -4.3783 | -5.5048 | -4.7025 |
|
Net Income/Loss
|
11.30%
-3.5628
|
-4.0165 | -4.3783 | -5.5064 | -4.7025 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
43.78%
12.76
|
8.8712 | 8.7591 | -0.1594 | 8.5344 |
| Diluted Average Shares |
43.78%
12.76
|
8.8712 | 8.7591 | -0.1862 | 8.5344 |
| Basic Earnings Per Share |
37.78%
-0.28
|
-0.45 | -0.50 | -0.65 | -0.55 |
| Diluted Earnings Per Share |
37.78%
-0.28
|
-0.45 | -0.50 | -0.65 | -0.55 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):